PET Imaging

Positron emission tomography (PET) is a nuclear imaging technology (also referred to as molecular imaging) that enables visualization of metabolic processes in the body. The basics of PET imaging is that the technique detects pairs of gamma rays emitted indirectly by a positron-emitting radionuclide (also called radiopharmaceuticals, radionuclides or radiotracer). The tracer is injected into a vein on a biologically active molecule, usually a sugar that is used for cellular energy. PET systems have sensitive detector panels to capture gamma ray emissions from inside the body and use software to plot to triangulate the source of the emissions, creating 3-D computed tomography images of the tracer concentrations within the body.

Feature

August 27, 2012 — Positron Corp., a molecular imaging healthcare company, announced the submission of a drug master file ...

Home August 27, 2012
Home
Technology

August 21, 2012 — The U.S. Food and Drug Administration (FDA) granted marketing approval for cfrQuant, coronary flow ...

Home August 21, 2012
Home
News

August 20, 2012 — Positron Corp. announced the use of its Attrius system at Caring Heart and Brain Imaging Inc. of ...

Home August 20, 2012
Home
News

August 14, 2012 — Positron Corp. announced the transfer, consolidation and integration of its radiopharmaceutical operat ...

Home August 14, 2012
Home
News

August 3, 2012 — FluoroPharma Medical Inc., a company specializing in the development of novel diagnostic imaging ...

Home August 03, 2012
Home
News

July 25, 2012 — Positron Corp. announced approval of a pledge for $15 million in tax increment financing (TIF) bonds fro ...

Home July 25, 2012
Home
News

July 13, 2012 — Royal Philips Electronics announced that it has embarked on a five-year joint research and development ...

Home July 13, 2012
Home
News

June 8, 2012 — At this year’s SNM Annual Meeting, June 9-13, Philips Healthcare is highlighting its portfolio of nuclear ...

Home June 08, 2012
Home
News

May 18, 2012 - New research from the University at Buffalo suggests that cardiologists may have a new way to identify ...

Home May 18, 2012
Home
Feature

April 27, 2012 — More than 150 molecular imaging professionals gathered last week at the Society of Nuclear Medicine’s ...

Home April 27, 2012
Home
Feature

April 9, 2012 — After witnessing a downtrend for several years, revenues in the U.S. nuclear medicine and positron ...

Home April 09, 2012
Home
News

April 6, 2012 — Positron Corp. announced the approval of its Nuclear Regulatory Commission (NRC) manufacturing and ...

Home April 06, 2012
Home
Feature

March 22, 2012 – Addressing concerns over radiation from cardiac imaging and procedures, the American College of ...

Home March 22, 2012
Home
News

January 30, 2012 — Positron Corp., a molecular imaging healthcare company specializing in the field of nuclear ...

Home January 30, 2012
Home
News

January 20, 2012 – Nuclear cardiology imaging company Positron Corp. this week acquired Manhattan Isotope Technology LLC ...

Home January 20, 2012
Home
Subscribe Now